Organophosphorus compounds (OPs)
pose great military
and civilian
hazards. However, therapeutic and prophylactic antidotes against OP
poisoning remain challenging. In this study, we first developed a
novel nanoscavenger (rOPH/ZIF-8@E-Lipo) against methyl paraoxon (MP)
poisoning using enzyme immobilization and erythrocyte–liposome
hybrid membrane camouflage techniques. Then, we evaluated the physicochemical
characterization, stability, and biocompatibility of the nanoscavengers.
Afterward, we examined acetylcholinesterase (AChE) activity, cell
viability, and intracellular reactive oxygen species (ROS) to indicate
the protective effects of the nanoscavengers in vitro. Following the pharmacokinetic and biodistribution studies, we further
evaluated the therapeutic and prophylactic detoxification efficacy
of the nanoscavengers against MP in various poisoning settings. Finally,
we explored the penetration capacity of the nanoscavengers across
the blood–brain barrier (BBB). The present study validated
the successful construction of a novel nanoscavenger with excellent
stability and biocompatibility. In vitro, the resulting
nanoscavenger exhibited a significant protection against MP-induced
AChE inactivation, oxidative stress, and cytotoxicity. In
vivo, apart from the positive therapeutic effects, the nanoscavengers
also exerted significant prophylactic detoxification efficacy against
single lethal MP exposure, repeated lethal MP challenges, and sublethal
MP poisoning. These excellent detoxification effects of the nanoscavengers
against OPs may originate from a dual-mode mechanism of inner recombinant
organophosphorus hydrolase (rOPH) and outer erythrocyte membrane-anchored
AChE. Finally, in vitro and in vivo studies jointly demonstrated that monosialoganglioside (GM1)-modified
rOPH/ZIF-8@E-Lipo could penetrate the BBB with high efficiency. In
conclusion, a stable and safe dual-modal nanoscavenger was developed
with BBB penetration capability, providing a promising strategy for
the treatment and prevention of OP poisoning.